News

14/05/2025

An Experimental Immunotherapy Reverses Heart Energy Damage Caused by Cholesterol

An international team of researchers has discovered how cholesterol can disrupt the internal functioning of the heart by accumulating in the mitochondria of cardiomyocytes. They have also developed an...

13/05/2025

The Sant Pau Research Institute Presents its New Strategic Plan 2025-2030

The Sant Pau Research Institute (IR Sant Pau) presented its new Strategic Plan 2025-2030 this Tuesday, in an event open to all research and healthcare staff. The plan will define the...

08/05/2025

Lipid Alterations Linked to Cardiovascular Risk Detected in People with Type 2 Diabetes

A recent study has identified specific alterations in lipid metabolism associated with subclinical atherosclerosis in individuals with type 2 diabetes. This silent condition, known as atherosclerosis,...

07/05/2025

Intravenous Administration of Atorvastatin Protects Against Infarction in the Presence of Diabetic Cardiomyopathy

Intravenous administration of atorvastatin during acute myocardial infarction could become a new therapeutic strategy capable of limiting infarct size in patients with diabetic cardiomyopathy, a heart...

30/04/2025

IR Sant Pau Strengthens Collaboration with Ephion Health and Joins the Startup’s Shareholding

The Sant Pau Research Institute (IR Sant Pau) has formalized a strategic agreement with Ephion Health, a company specialized in developing artificial intelligence technologies for monitoring mobility ...